Sort
48,018 grants matching “immunotherapy”
Developing preclinical xenograft models in zebrafish.
$794,628David Michael Langenau · Massachusetts General Hospital · R24 · FY2024 · OD
Developing preclinical xenograft models in zebrafish.
$794,628David Michael Langenau · Massachusetts General Hospital · R24 · FY2023 · OD
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere
$794,519Paul John Norman · University Of Colorado Denver · R01 · FY2022 · AI
Development of Drugs Acting at Adenosine Receptors
$794,513Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Regulation of innate lymphocyte function
$794,415Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
$794,337Justin M Balko · Vanderbilt University Medical Center · R01 · FY2024 · HL
Strategies for Prevention of Autoimmunity
$794,026Stanford University · U19 · FY2001 · DK
Metformin for chemoprevention of lung cancer in obese subjects at high risk
$794,005Saikrishna Yendamuri · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Targeting virus-specific CAR T cells to lymphoid follicles to achieve durable HIV suppression
$793,546Pamela J Skinner · University Of Minnesota · R01 · FY2021 · AI
Engineering knotted peptide therapeutics for pediatric brain tumor patients
$793,459James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Pathogenesis of Hepatitis B Virus in Transgenic Mice
$792,726Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2008 · CA
NK/DC Cross-Talk and Antiviral Response
$792,714Luis J. Montaner · Wistar Institute · R01 · FY2010 · AI
Data-driven inference of regulators for cytokine-mediated tumor killing
$792,649Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of botulinum neurotoxin immunotherapy
$792,374James D. Marks · University Of California, San Francisco · U01 · FY2007 · AI
NP855 for Targeting Thyrointegrin αvβ3 receptors and Norepinephrine Transporter in Neuroblastoma Management
$792,367Paul Davis · Nanopharmaceuticals, Llc · R44 · FY2024 · CA
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$791,948Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2023 · AI
Clinical Protocol and Data Management
$791,885Vicki Leigh Keedy · Vanderbilt University Medical Center · P30 · FY2020 · CA
Clinical Protocol and Data Management
$791,885Elizabeth J Davis · Vanderbilt University Medical Center · P30 · FY2023 · CA
Clinical Protocol and Data Management
$791,885Elizabeth J Davis · Vanderbilt University Medical Center · P30 · FY2024 · CA
Clinical Protocol and Data Management
$791,885Vicki Leigh Keedy · Vanderbilt University Medical Center · P30 · FY2021 · CA
Clinical Protocol and Data Management
$791,885Elizabeth J Davis · Vanderbilt University Medical Center · P30 · FY2022 · CA
3BNC117 and 10-1074 to suppress HIV-1 replication and reduce the reservoir
$791,861Marina Caskey · Rockefeller University · U01 · FY2019 · AI
Receptor Mediated T and B Cell Activation
$791,759Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Persistent Immunogenicity of IDLV delivering Gag and membrane tethered HIV-1 Envelope Trimers
$791,661Maria Blasi · Duke University · R01 · FY2025 · AI
Effects of systemic and topical perturbations on human microbes
$791,525Heidi Kong · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR